Mutations of the p53 tumor suppressor gene may predict radiotherapy failure in head and neck cancer patients
β Scribed by David Brachman; Deborah Graves; Michael Beckett; Daniel Haraf; Everett Vokes; Ralph R. Weichselbaum
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 103 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We investigated the prognostic significance of p53-gene mutation (exon 5-9) and bcl-2-protein expression in primary squamous-cell carcinoma of the head and neck (HNSCC) treated by curative radiotherapy (RT). Primary squamouscell carcinomas for analysis were obtained from 85 consecutive head-and-neck
## Abstract The incidence and pattern of mutations of the __ras__ oncogenes and the __p53__ tumor suppressor gene have been shown to differ among different cancer types and even among the same cancer types with different etiological backgrounds. For example, in a previous study we showed that not o
## Detection of mutations and polymorphisms in the p53 tumor suppressor gene by single-strand conformation polymorphism analysis Deciphering the genetic mechanisms in cancer development requires analysis of a large number of tumors for consistent genetic alterations. Single-strand conformational p
Communicaced by R. G . H. Cotron Germline and somatic mutations in the p53 and APC genes contribute to neoplasia. The patterns of these and other acquired mutations in cancers reflect environmental mutagens and endogenous factors that contribute to carcinogenesis. Herein, we describe a database of a